NCT01396590已完成1 期
A Randomized, Open-label, Crossover Study to Demonstrate Bioequivalence Between 6 ? 2-mg Tablets of Perampanel and a Single 12-mg Tablet of Perampanel in Healthy Subjects
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Eisai Inc.
- 入组人数
- 54
- 主要终点
- Cmax of 6 x 2-mg perampanel tablets (reference) compared to that of the 12-mg perampanel tablet (test)
研究概览
简要总结
The purpose of this study is to determine that six 2-mg tablets of perampanel are bioequivalent to one 12-mg tablet of perampanel.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 55 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
6 x 2 mg perampanel
Active Comparator
干预措施: Perampanel (Drug)
12 mg Perampanel
Active Comparator
干预措施: Perampanel (Drug)
结局指标
主要结局
Cmax of 6 x 2-mg perampanel tablets (reference) compared to that of the 12-mg perampanel tablet (test)
时间窗: 8 days
AUC(0-t) of 6 x 2-mg perampanel tablets (reference) compared to that of the 12-mg perampanel tablet (test)
时间窗: 8 days
AUC(0-inf) of 6 x 2-mg perampanel tablets (ref) compared to that of the 12-mg perampanel tablet (test)
时间窗: 8 days
次要结局
- The incidence of AEs(8 days)
研究者
相似试验
已完成
1 期
Demonstrate Bioequivalence Between 3 x 2-mg Tablets of Perampanel and a Single 6-mg Tablet of Perampanel in Healthy SubjectsHealthyNCT01396577Eisai Inc.54
已完成
1 期
A Study to Demonstrate Bioequivalence Between 6 x 2 mg Tablets of Perampanel and a Single 12 mg Tablet of Perampanel in Healthy SubjectsPartial Onset EpilepsyNCT01240187Eisai Inc.22
已完成
1 期
A Study to Investigate the Potential Pharmacokinetic Interaction of Perampanel With Oral Contraceptives in Healthy Female SubjectsPartial Onset EpilepsyNCT01209858Eisai Inc.48
已完成
2 期
A Study of Intravenous Perampanel in Japanese Participants With EpilepsySeizuresEpilepsyNCT03754582Eisai Co., Ltd.21
已完成
3 期
A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic SeizuresSeizure Disorder Generalized Tonic ClonicNCT01393743Eisai Inc.163